Phase I study of sorafenib in patients with refractory or relapsed acute leukemias

Gautam Borthakur, Hagop Kantarjian, Farhad Ravandi, Weiguo Zhang, Marina Konopleva, John J. Wright, Stefan Faderl, Srdan Verstovsek, Sheela Mathews, Michael Andreeff, Jorge E. Cortes

Research output: Contribution to journalArticlepeer-review

137 Scopus citations

Fingerprint Dive into the research topics of 'Phase I study of sorafenib in patients with refractory or relapsed acute leukemias'. Together they form a unique fingerprint.

Medicine & Life Sciences